Viewing Study NCT06025695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-02-03 @ 1:21 PM
Study NCT ID: NCT06025695
Status: COMPLETED
Last Update Posted: 2025-05-09
First Post: 2023-08-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastroenteritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rotavirus (RV) View
None Human rotavirus (HRV) View
None Rotarix Porcine circovirus (PCV)-free liquid View
None Rotarix liquid View
None Healthy Chinese infants View
None Immunogenicity View
None Reactogenicity View
None Safety View